Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.42M 1.33M 1.21M 2.29M 156M 2.32M 15.57M 6.11M 78.27M 6.16M 6.03M 261M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.04M 6.58M 6.01M 11.33M 775M 11.51M 77.13M 30.27M 388M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+3.90%+8.11%+90.85%+132.54% 1,057B
+0.99%+2.04%+49.36%+50.79% 625B
+0.78%-0.31%+23.01%+61.35% 435B
+1.58%+5.51%+51.42%+40.47% 363B
+0.65%+0.16%+34.81%+39.85% 296B
+0.79%-5.08%+9.78%+7.23% 249B
+1.52%+8.73%+44.49%+57.19% 222B
+0.34%-0.11%-5.23%-51.54% 209B
-0.11%+1.55%+10.55%+66.48% 165B
Average -9.29%+3.10%+34.34%+44.93% 402.31B
Weighted average by Cap. +1.04%+3.98%+49.38%+66.21%

Financials

2007 2008
Net sales 23.47M 20.31M 18.99M 17.35M 32.7M 2.24B 33.21M 223M 87.37M 1.12B 88.11M 86.19M 3.73B 25.96M 22.47M 21.01M 19.2M 36.18M 2.48B 36.74M 246M 96.66M 1.24B 97.48M 95.35M 4.13B
Net income -20.86M -18.06M -16.88M -15.43M -29.07M -1.99B -29.52M -198M -77.66M -995M -78.32M -76.61M -3.31B -4.01M -3.47M -3.24M -2.96M -5.58M -382M -5.67M -38.01M -14.91M -191M -15.04M -14.71M -637M
Net Debt 18.79M 16.27M 15.2M 13.9M 26.19M 1.79B 26.6M 178M 69.96M 897M 70.55M 69.02M 2.99B 6.49M 5.62M 5.25M 4.8M 9.04M 619M 9.18M 61.57M 24.16M 310M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-